This implant can restore sight for patients with macular degeneration
More than 5 million people around the world have an advanced form of age-related macular degeneration (AMD) called geographic atrophy, in which cells in the retinas die off. And until now, no treatment could restore their vision. The PRIMA system, which was approved in Europe in July and is awaiting FDA clearance in the US,…
What happened
More than 5 million people around the world have an advanced form of age-related macular degeneration (AMD) called geographic atrophy, in which cells in the retinas die off. And until now, no treatment could restore their vision. The PRIMA system, which was approved in Europe in July and is awaiting FDA clearance in the US,…
Why it matters
The development may change operating conditions or market expectations around AMD. Further confirmation and measurable outcomes matter.
Affected entities
View evidence
1 reports · 1 original report · 1 independent
- MIT Technology ReviewPrimary source · Supports · EN · 100%This implant can restore sight for patients with macular degeneration ↗
Claims
- This implant can restore sight for patients with macular degeneration Observed
Conflicts
No material conflict detected in the available evidence.
Timeline
- First reported
Market move following event
Market reaction is not yet available for this asset and time window.